Bansi Desai
Stock Analyst at J.P. Morgan
(2.77)
# 2,823
Out of 5,020 analysts
72
Total ratings
43.5%
Success rate
4.1%
Average return
Main Sectors:
Stocks Rated by Bansi Desai
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: ALKEM Alkem Laboratories Limited | Reiterated: Hold | ₹5,900 → ₹6,100 | ₹5,220 | +16.86% | 6 | Aug 17, 2026 | |
| NSE: ZYDUSLIFE Zydus Lifesciences Limited | Reiterated: Hold | ₹1,050 → ₹1,240 | ₹1,146 | +8.23% | 5 | Aug 12, 2026 | |
| NSE: FORTIS Fortis Healthcare Limited | Reiterated: Buy | ₹1,120 → ₹1,180 | ₹785.00 | +50.32% | 6 | Aug 10, 2026 | |
| NSE: LUPIN Lupin Limited | Reiterated: Hold | ₹2,600 → ₹2,700 | ₹2,031 | +32.93% | 6 | Aug 10, 2026 | |
| NSE: DIVISLAB Divi's Laboratories Limited | Reiterated: Buy | ₹7,400 → ₹9,100 | ₹9,249 | -1.61% | 3 | Aug 4, 2026 | |
| NSE: MANKIND Mankind Pharma Limited | Downgraded: Hold | ₹2,850 → ₹2,700 | ₹2,535 | +6.51% | 7 | Aug 4, 2026 | |
| NSE: CIPLA Cipla Limited | Reiterated: Buy | ₹1,550 → ₹1,600 | ₹1,344 | +19.05% | 6 | Jul 28, 2026 | |
| NSE: ANTHEM Anthem Biosciences Limited | Reiterated: Buy | ₹850.00 → ₹900.00 | ₹858.50 | +4.83% | 4 | Jul 23, 2026 | |
| NSE: BLUEJET Blue Jet Healthcare Limited | Reiterated: Sell | ₹600.00 → ₹370.00 | ₹542.00 | -31.73% | 4 | May 27, 2026 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Reiterated: Sell | ₹1,090 → ₹1,150 | ₹1,206 | n/a | 4 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹34,500 → ₹37,000 | ₹26,840 | n/a | 5 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹1,350 → ₹1,550 | ₹1,945 | n/a | 3 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹1,240 → ₹1,480 | ₹1,357 | n/a | 2 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹2,030 → ₹1,970 | ₹1,801 | n/a | 4 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,700 → ₹1,840 | ₹1,280 | n/a | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,390 → ₹1,325 | ₹940.95 | n/a | 2 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹8,800 | ₹8,134 | n/a | 1 | Feb 12, 2025 |
Alkem Laboratories Limited
Aug 17, 2026
Reiterated: Hold
Price Target: ₹5,900 → ₹6,100
Current: ₹5,220
Upside: +16.86%
Zydus Lifesciences Limited
Aug 12, 2026
Reiterated: Hold
Price Target: ₹1,050 → ₹1,240
Current: ₹1,146
Upside: +8.23%
Fortis Healthcare Limited
Aug 10, 2026
Reiterated: Buy
Price Target: ₹1,120 → ₹1,180
Current: ₹785.00
Upside: +50.32%
Lupin Limited
Aug 10, 2026
Reiterated: Hold
Price Target: ₹2,600 → ₹2,700
Current: ₹2,031
Upside: +32.93%
Divi's Laboratories Limited
Aug 4, 2026
Reiterated: Buy
Price Target: ₹7,400 → ₹9,100
Current: ₹9,249
Upside: -1.61%
Mankind Pharma Limited
Aug 4, 2026
Downgraded: Hold
Price Target: ₹2,850 → ₹2,700
Current: ₹2,535
Upside: +6.51%
Cipla Limited
Jul 28, 2026
Reiterated: Buy
Price Target: ₹1,550 → ₹1,600
Current: ₹1,344
Upside: +19.05%
Anthem Biosciences Limited
Jul 23, 2026
Reiterated: Buy
Price Target: ₹850.00 → ₹900.00
Current: ₹858.50
Upside: +4.83%
Blue Jet Healthcare Limited
May 27, 2026
Reiterated: Sell
Price Target: ₹600.00 → ₹370.00
Current: ₹542.00
Upside: -31.73%
Dr. Reddy's Laboratories Limited
Aug 19, 2025
Reiterated: Sell
Price Target: ₹1,090 → ₹1,150
Current: ₹1,206
Upside: n/a
Aug 15, 2025
Reiterated: Buy
Price Target: ₹34,500 → ₹37,000
Current: ₹26,840
Upside: n/a
Aug 11, 2025
Reiterated: Hold
Price Target: ₹1,350 → ₹1,550
Current: ₹1,945
Upside: n/a
Aug 11, 2025
Reiterated: Hold
Price Target: ₹1,240 → ₹1,480
Current: ₹1,357
Upside: n/a
Aug 1, 2025
Reiterated: Buy
Price Target: ₹2,030 → ₹1,970
Current: ₹1,801
Upside: n/a
Jul 29, 2025
Reiterated: Buy
Price Target: ₹1,700 → ₹1,840
Current: ₹1,280
Upside: n/a
May 22, 2025
Reiterated: Buy
Price Target: ₹1,390 → ₹1,325
Current: ₹940.95
Upside: n/a
Feb 12, 2025
Reiterated: Buy
Price Target: ₹8,800
Current: ₹8,134
Upside: n/a